Genpharmasec Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	1,399	337.22	304.06	255.16	273.21
Other Revenue	31.57	-	-	-	-
Revenue	1,431	337.22	304.06	255.16	273.21
Revenue Growth (YoY)	324.34%	10.91%	19.16%	-6.61%	28.22%
Cost of Revenue	1,286	295.48	242.33	233.97	265.65
Gross Profit	145.15	41.74	61.73	21.18	7.55
Selling, General & Admin	38.7	10.29	9.18	6.83	3.59
Other Operating Expenses	62.65	30.81	52.09	11.67	9.18
Operating Expenses	123.04	49.21	61.69	18.7	12.91
Operating Income	22.11	-7.47	0.04	2.48	-5.36
Interest Expense	-12.4	-4.34	-4.09	-0.56	-
Interest & Investment Income	-	2.35	0	0.31	0.65
Currency Exchange Gain (Loss)	-	0.96	1.83	0.55	0.16
Other Non Operating Income (Expenses)	0	-0	-0	0.04	0.11
EBT Excluding Unusual Items	9.71	-8.51	-2.22	2.82	-4.43
Gain (Loss) on Sale of Investments	-	27.31	4.73	-	-
Pretax Income	9.71	18.8	2.51	2.82	-4.43
Income Tax Expense	4.11	6.49	4.2	-8.43	-2.34
Earnings From Continuing Operations	5.6	12.31	-1.69	11.25	-2.09
Minority Interest in Earnings	10.43	-	-	-	-
Net Income	16.03	12.31	-1.69	11.25	-2.09
Net Income to Common	16.03	12.31	-1.69	11.25	-2.09
Net Income Growth	30.22%	-	-	-	-
Shares Outstanding (Basic)	1,603	554	307	277	277
Shares Outstanding (Diluted)	1,603	554	307	277	277
Shares Change (YoY)	189.55%	80.25%	10.96%	-	2.06%
EPS (Basic)	0.01	0.02	-0.01	0.04	-0.01
EPS (Diluted)	0.01	0.02	-0.01	0.04	-0.01
EPS Growth	-50.00%	-	-	-	-
Free Cash Flow	-180.73	-27.19	-29.64	-30.76	-24.25
Free Cash Flow Per Share	-0.11	-0.05	-0.10	-0.11	-0.09
Gross Margin	10.14%	12.38%	20.30%	8.30%	2.77%
Operating Margin	1.54%	-2.22%	0.01%	0.97%	-1.96%
Profit Margin	1.12%	3.65%	-0.56%	4.41%	-0.77%
Free Cash Flow Margin	-12.63%	-8.06%	-9.75%	-12.05%	-8.88%
EBITDA	43.79	-4.02	0.21	2.68	-5.21
EBITDA Margin	3.06%	-1.19%	0.07%	1.05%	-1.91%
D&A For EBITDA	21.68	3.45	0.17	0.2	0.14
EBIT	22.11	-7.47	0.04	2.48	-5.36
EBIT Margin	1.54%	-2.22%	0.01%	0.97%	-1.96%
Effective Tax Rate	42.30%	34.52%	167.56%	-	-
Revenue as Reported	1,431	367.84	310.62	256.16	274.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.